Literature DB >> 19506994

Triple negative breast cancer: clinicopathological characteristics and treatment strategies.

Futoshi Akiyama1, Hirotaka Iwase.   

Abstract

Triple negative breast cancer (TNBC) is defined as a subtype that is negative for estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2. We introduce the theme of the special issue concerning clinicopathological characteristics and prospective treatment strategies of TNBC. This special issue consists of five conference papers that have been agreed on by the speakers and the commentator of the symposium of the 16th Annual Meeting of the Japanese Breast Cancer Society in September 2008 in Osaka.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19506994     DOI： 10.1007/s12282-009-0140-x

Source DB:  PubMed          Journal:  Breast Cancer        ISSN： 1340-6868            Impact factor:   4.239


  6 in total

1.  Clinicopathological features of triple-negative breast cancer in Taiwanese women.

Authors:  Kuo Yao-Lung; Chen Dar-Ren; Chang Tsai-Wang
Journal:  Int J Clin Oncol       Date:  2011-04-01       Impact factor: 3.402

2.  Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the U.S.--a SEER analysis.

Authors:  Madhuri Kakarala; Laura Rozek; Michele Cote; Samadhi Liyanage; Dean E Brenner
Journal:  BMC Cancer       Date:  2010-05-11       Impact factor: 4.430

3.  Ultrasound and clinicopathological characteristics of triple receptor-negative breast cancers.

Authors:  Yoon Jung Choi; Min Hyun Seong; Seon Hyeong Choi; Shin Ho Kook; Hyon Joo Kwag; Yong Lai Park; Chan Heun Park
Journal:  J Breast Cancer       Date:  2011-06-18       Impact factor: 3.588

4.  Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients.

Authors:  Gul Alco; Atilla Bozdogan; Derya Selamoglu; Kezban Nur Pilanci; Sitki Tuzlali; Cetin Ordu; Sefik Igdem; Sait Okkan; Maktav Dincer; Gokhan Demir; Vahit Ozmen
Journal:  Oncol Lett       Date:  2015-01-07       Impact factor: 2.967

5.  Depsidones inhibit aromatase activity and tumor cell proliferation in a co-culture of human primary breast adipose fibroblasts and T47D breast tumor cells.

Authors:  Suthat Chottanapund; M B M Van Duursen; Anne Zwartsen; Supatchaya Timtavorn; Panida Navasumrit; Prasat Kittakoop; Sanya Sureram; Mathuros Ruchirawat; Martin Van den Berg
Journal:  Toxicol Rep       Date:  2017-03-19

6.  CD8(+) tumor-infiltrating lymphocytes contribute to spontaneous "healing" in HER2-positive ductal carcinoma in situ.

Authors:  Michi Morita; Rin Yamaguchi; Maki Tanaka; Gary M Tse; Miki Yamaguchi; Naoki Kanomata; Yoshiki Naito; Jun Akiba; Satoshi Hattori; Shigeki Minami; Susumu Eguchi; Hirohisa Yano
Journal:  Cancer Med       Date:  2016-04-06       Impact factor: 4.452
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.